These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2007-004102-27 A Randomized, Double Blind, Placebo Controlled, Phase II Study Evaluating the Efficacy and Safety of RP101 in Combination with Gemcitabine Administered as First-Line Treatment to Subjects with Unresec... 2009-10-02 bad-data
Completed, but no date, and reported results Terminated 2015-005605-36 Thymosin alpha 1 plus maintenance therapy with the Standard of Care (SoC) chemotherapy plus cisplatin (or carboplatin) in patients with metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR wild type ... bad-data
Other 2019-001441-40 A phase II trial to assess the activity and tolerability of Thymosin alpha 1 in Cystic Fibrosis Patients. Studio di Fase II per determinare l’attività e la tollerabilità di Timosina alfa 1 in pazi... not-yet-due